Breakout Buys: Tata Steel, BSE, Vedanta And Sun Pharma Poised For Upside

Published : Oct 10, 2025, 11:10 AM IST
https://stocktwits.com/news-articles/markets/equity/breakout-buys-tata-steel-bse-vedanta-and-sun-pharma-poised-for-upside/ch6aZYjR31V

Synopsis

These four stocks have shown strong technical setups backed by heavy volumes.

Market analysts have identified multiple breakout opportunities across key sectors, including metals, pharma, and capital market stocks. SEBI-registered analyst Financial Sarthis flagged two strong breakout stocks to watch: Vedanta and Sun Pharma. While Palak Jain is bullish on BSE and Tata Steel. 

Let’s take a look at their stock recommendations: 

Tata Steel

Tata Steel has seen a resistance breakout with substantial volumes after a tight consolidation range. It is now showing new bullish momentum and a clear entry above 176.

Palak Jain believes that its strong brand backing, improving business outlook, stable earnings, and positive sector tailwinds hold well for the stock going forward. Additionally, the risk-reward is attractive from a breakout, with a stop firmly below the recent support zone.

She advised buying Tata Steel above ₹176, with a stop loss at ₹165 for target prices of ₹181, ₹187, and ₹197.

Bombay Stock Exchange (BSE)

Jain noted a flag and pole pattern breakout in BSE above ₹2,335 on the weekly chart with strong volumes. The stock is showing a fresh uptrend after a healthy correction phase. Flagpole breakout flips resistance to support, providing a clean swing setup opportunity with clear targets and well-defined stoploss for risk control, she added.

Jain advised buying BSE above ₹2,335, with a stop loss at ₹2,202 for target prices of ₹2,405, ₹2,475, and ₹2,615.

Vedanta

Financial Sarthis noted a flat horizontal breakout in Vedanta. The strong surge in volumes confirmed strong buying interest in the utilities space. They see a gap fill towards ₹494-₹496 and then towards ₹510-₹515 levels. 

 Sun Pharma

Financial Sathis also flagged a flat horizontal breakout in Sun Pharma, supported by huge volume buying. They believe the stock could now test ₹1,690 & ₹1,740 with support at ₹1,630.

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Read more Articles on

Recommended Stories

Eli Lilly Stock Falls For 9 Straight Days Despite $6B Push To Build A US Plant For Its Oral GLP-1 Pill
SpaceX Targets $1.5T Valuation In IPO That Could Become The Biggest Listing Ever: Report